Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Bioorg Med Chem. 2008 Feb 15;16(4):1648-57. Epub 2007 Nov 17.

Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer.

Author information

  • 1Department of Chemistry and Biochemistry and Notre Dame Cancer Research Center, University of Notre Dame, Notre Dame, IN 46556, USA.

Abstract

A siderophore conjugate was designed as a potential PSMA inhibitor and diagnostic agent for prostate cancer. A semi-rigid spacer was incorporated to avoid competitive participation of iron binding by the enzyme inhibitor relative to the siderophore component. Biological test results showed that, even with the extended scaffold, this compound is a potent PSMA inhibitor with an IC50 of 4 nM. This siderophore conjugate may be useful for detection of prostate-derived cancer cells by magnetic resonance imaging (MRI).

PMID:
18060794
[PubMed - indexed for MEDLINE]
PMCID:
PMC2701565
Free PMC Article

Images from this publication.See all images (7)Free text

Figure 2
Scheme 1
Scheme 4
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk